Patents by Inventor Ying Wang Schmidt

Ying Wang Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9446006
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine, carnitine, B vitamins (B1, B2, B3, B5, B6, and/or B12) and ginseng (preferably: root) extract.can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: September 20, 2016
    Assignee: DSM IP ASSETS B.V.
    Inventors: Ann Fowler, Angelika Friedel, Darko Knutti, Karin Kuratli, Daniel Raederstorff, Ying Wang-Schmidt, Karin Wertz
  • Patent number: 9241938
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: January 26, 2016
    Assignee: DSM IP ASSETS B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Publication number: 20150079206
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: November 20, 2014
    Publication date: March 19, 2015
    Inventors: Angelika FRIEDEL, Karin KURATLI, Christof WEHRLI, Karin WERTZ, Swen WOLFRAM, Ying WANG-SCHMIDT
  • Publication number: 20150030579
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine, carnitine, B vitamins (B1, B2, B3, B5, B6, and/or B12) and ginseng (preferably: root) extract. can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Application
    Filed: August 1, 2014
    Publication date: January 29, 2015
    Applicant: DSM IP ASSETS B.V.
    Inventors: Ann FOWLER, Angelika FRIEDEL, Darko KNUTTI, Karin KURATLI, Daniel RAEDERSTORFF, Ying WANG-SCHMIDT, Karin WERTZ
  • Publication number: 20140194531
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol ca in can he used to maintain or increase mitochondria(biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Application
    Filed: January 6, 2014
    Publication date: July 10, 2014
    Applicant: DSM IP Assets B.V.
    Inventors: Jiankang LIU, Daniel RAEDERSTORFF, Ying WANG-SCHMIDT, Karin WERTZ
  • Patent number: 8772230
    Abstract: This invention relates to the use of niacin and/or trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: July 8, 2014
    Assignee: DSM IP Assets B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Patent number: 8420677
    Abstract: Use of DIM and/or its derivatives for prevention, treatment and/or delay of age-related hearing loss in mammals.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: April 16, 2013
    Assignee: DSM IP Assets B.V.
    Inventors: Hubert Hug, Bernd Mussler, Daniel Raederstorff, Ying Wang-Schmidt
  • Publication number: 20130018076
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: September 7, 2012
    Publication date: January 17, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: Angelika FRIEDEL, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Patent number: 8323707
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: December 4, 2012
    Assignee: DSM IP Assets B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Publication number: 20120302645
    Abstract: The use of hydroxytyrosol or an olive juice extract containing hydroxytyrosol for improving muscle differentiation and thus improving or maintaining the body's adaptation to exercise is disclosed. The pharmaceutical and nutraceutical compositions comprising hydroxytyrosol useful for conditions characterized by altered muscle differentiation especially under inflammatory conditions, such as delayed onset muscle soreness subsequent to strenuous exercise or sarcopenia are provided.
    Type: Application
    Filed: October 8, 2010
    Publication date: November 29, 2012
    Inventors: Jiankang Liu, Ying Wang-Schmidt, Karin Wertz, Zhihui Feng
  • Publication number: 20120225840
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine, carnitine, B vitamins (B1, B2, B3, B5, B6, and/or B12) and ginseng (preferably: root) extract can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Application
    Filed: October 15, 2009
    Publication date: September 6, 2012
    Inventors: Ann Fowler, Angelika Friedel, Darko Knutti, Karin Kuratli, Daniel Raederstorff, Ying Wang-Schmidt, Karin Wertz
  • Patent number: 8242168
    Abstract: The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: August 14, 2012
    Assignee: DSM IP Assets B.V.
    Inventors: Daniel D'Orazio, Antoine De Saizieu, Goede Schueler, Daniel Raederstorff, Sandra Renata Teixeira, Ying Wang Schmidt, Peter Weber, Swen Wolfram
  • Publication number: 20120190617
    Abstract: This invention relates to the use of niacin and/or trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: June 10, 2010
    Publication date: July 26, 2012
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Patent number: 8227508
    Abstract: The present invention refers to carnosol and rosmanol for use (as medicament) in the treatment of a disorder connected to reduced neurotransmission, cognitive dysfunction and/or symptoms caused by headache and/or migraine, as well as to dietary and pharmaceutical compositions and their uses.
    Type: Grant
    Filed: November 22, 2007
    Date of Patent: July 24, 2012
    Assignees: DSM IP Assets B.V., Nestec S.A.
    Inventors: Ann Fowler, Regina Goralczyk, Claus Kilpert, Hasan Mohajeri, Daniel Raederstorff, Antoine De Saizieu, Goede Schueler, Ying Wang-Schmidt, Christof Wehrli
  • Publication number: 20110190367
    Abstract: Use of DIM and/or its derivatives for prevention, treatment and/or delay of age-related hearing loss in mammals.
    Type: Application
    Filed: February 19, 2009
    Publication date: August 4, 2011
    Inventors: Hubert Hug, Bernd Mussler, Daniel Raederstorff, Ying Wang-Schmidt
  • Publication number: 20110142974
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: December 3, 2010
    Publication date: June 16, 2011
    Applicant: DSM IP ASSETS B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Publication number: 20110112201
    Abstract: Hydroxytyrosol or olive juice containing hydroxytyrosol can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
    Type: Application
    Filed: April 17, 2009
    Publication date: May 12, 2011
    Inventors: Jiankang Liu, Daniel Raederstorff, Ying Wang-Schmidt, Karin Wertz
  • Publication number: 20100130621
    Abstract: The present invention is directed to the use of (a composition comprising) hydroxytyrosol as anti-aging agent. The composition, to which the present invention is also directed, does essentially not comprise resveratrol and is administered orally to animals. The present invention is further directed to anti-aging methods. “Anti-aging” meaning in the context of the present invention: retarding the aging processes in said animals, improving age-related physiological deficits in said animals and/or promoting a healthy aging in said animals.
    Type: Application
    Filed: April 17, 2008
    Publication date: May 27, 2010
    Applicant: DSM IP ASSETS B.V.
    Inventors: Daniel Raederstorff, Ying Wang-Schmidt, Karin Wertz
  • Publication number: 20100130620
    Abstract: The present invention is directed to the use of (a composition comprising) hydroxytyrosol for treating or preventing age-related macular degeneration in humans, for maintaining the eye health in animals (preferably in humans), especially in elderly animals (preferably elderly humans), for improving the vision of animals (preferably of humans), for maintaining the high resolution vision in animals (preferably in humans) and/or for maintaining the visual acuity in animals (preferably in humans), as well as for maintaining the visual performance in animals (preferably in humans) and/or the visual function in animals (preferably in humans).
    Type: Application
    Filed: April 18, 2007
    Publication date: May 27, 2010
    Inventors: Jiankang Liu, Wolfgang Schalch, Ying Wang-Schmidt, Karin Wertz
  • Publication number: 20100113612
    Abstract: The present invention is directed to the use of (a composition comprising) hydroxytyrosol as life prolonging agent. The composition, to which the present invention is also directed, does essentially not comprise resveratrol and is preferably administered orally to animals. The present invention is further directed to a life prolonging method. “Life prolonging” meaning in the context of the present invention: reducing the risk to die at a certain age compared to untreated; increasing the chance to live longer (longevity), i.e. increasing the average life expectancy compared to untreated; and/or extending the lifetime independent of medical care.
    Type: Application
    Filed: April 17, 2008
    Publication date: May 6, 2010
    Inventors: Daniel Raederstorff, Ying Wang-Schmidt, Karin Wertz